Whether interaction of PADs with PP2A-inhibitory interactors (such as reported for FTY720 and I2PP2A/SET in the regulation of tumor suppression7) is responsible for their beneficial actions in respiratory inflammation is unknown at present and warrants further in-depth investigation. The gene discussed is PTPA; the disease is neoplasm.